Benzinga | Aug 11, 2021 04:15PM EDT

Revolution Medicines Q2 EPS $(0.60) Misses $(0.56) Estimate, Sales $8.70M Miss $9.38M Estimate

Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.56) by 7.14 percent. This is a 30.43 percent decrease over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $8.70 million which missed the analyst consensus estimate of $9.38 million by 7.27 percent. This is a 13.24 percent decrease over sales of $10.03 million the same period last year.